FOXP3+ T cells in uterine sarcomas are associated with favorable prognosis, low extracellular matrix expression and reduced YAP activation

Uterine sarcomas are rare but deadly malignancies without effective treatment. Immunotherapy is a promising new approach to treat these tumors but has shown heterogeneous effects in sarcoma patients. With the goal of identifying key factors for improved patient treatment, we characterized the tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Gultekin, Okan, Gonzalez-Molina, Jordi, Hardell, Elin, Moyano-Galceran, Lidia, Mitsios, Nicholas, Mulder, Jan, Kokaraki, Georgia, Isaksson, Anders, Sarhan, Dhifaf, Lehti, Kaisa, Carlson, Joseph W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604926/
https://www.ncbi.nlm.nih.gov/pubmed/34799669
http://dx.doi.org/10.1038/s41698-021-00236-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604926/
https://www.ncbi.nlm.nih.gov/pubmed/34799669
http://dx.doi.org/10.1038/s41698-021-00236-6

Ejemplares similares